NSCLC Lung Cancer Treatments

Nivolumab nsclc lung cancer treatments

There are two types of lung cancer: the first is called small cell lung cancer (SCLC), and the second is called non-small cell lung cancer (NSCLC). Roughly 80 to 85% of lung cancers are diagnosed as NSCLC. Luckily, there are various NSCLC treatments, and a good example would be . NSCLC lung cancer treatments have their benefits, so here’s everything you should know before going down this path.

NSCLC Lung Cancer Treatments

—sold under the brand name —is a checkpoint inhibitor that targets PD-1. essentially works by boosting an individual’s immune response against cancer cells. It is given intravenously. The session lasts roughly 60 minutes, and is given roughly every two weeks. NSCLC lung cancer treatments will depend on how severe the cancer is. 

Things to Know

If you are thinking about starting for NSCLC treatment, it is crucial that you mention to your doctor if you have an autoimmune disease. If you do, you will not be recommended to start  NSCLC lung cancer treatments. Further, let your doctor know if you’ve ever had an organ transplant, liver problems, or trouble breathing. 

Side Effects of  

There are side effects of when used to treat NSCLC patients. The most common side effects include fatigue and joint and/or muscle pain. With that said, other NSCL patients have said they have experienced other side effects, such as constipation, cough, and decreased appetite. 

can cause other side effects, but they are not as common among NSCLC patients. Nonetheless, it doesn’t hurt to know what they are. This way you can be alerted early on if something is wrong. Other side effects include the following: nausea, rash and/or itchy skin, diarrhea, shortness of breath, fever, and upper respiratory infection. 

Seek medical attention if you experience any sort of side effect after starting NSCLC lung cancer treatments. 

Featured Image: Depositphotos/ ©alexskopje

Posted on May 5, 2023